In this article

Brello combines medication plans with an app, fitness and nutrition classes, and a community. An alternative needs to be compared against the parts you actually use, as well as the medication and prescribing arrangement.

The current Brello page pairs monthly-equivalent prices with a three-month minimum and an 11-week renewal schedule. Those timing details are central to this comparison: a cheaper-looking monthly number can still require a longer commitment.

THE SHORT ANSWER

Start with the renewal calendar and the support you use, then compare the exact prescription and full payment obligation. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.

What to know first

  • Start with the renewal calendar and the support you use, then compare the exact prescription and full payment obligation.
  • CoreAge Rx is the first listing through a disclosed commercial arrangement.
  • Confirm the proposed product, care arrangement, and complete written payment terms.

How this shortlist was selected

CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.

Start with the renewal calendar and the support you use, then compare the exact prescription and full payment obligation. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.

01. CoreAge Rx — featured partner

Our sponsored benchmark for a self-pay program without a separate advertised membership fee. Verify the chosen term before treating the starting price as a flexible monthly alternative.

The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.

The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.

Continue with our CoreAge Rx review and pricing details.

02. Coby Health

Worth comparing when a monthly option matters more than a bundled community. Its public description makes the consultation format and pharmacy-stage cancellation limits particularly relevant.

Coby Health offers monthly and multi-month compounded GLP-1 plans and says there are no membership fees. The homepage reviewed did not provide a single complete dollar quote applicable to every plan.

Its policy describes a $50 visit-and-clinical fee deduction if a pre-pharmacy cancellation is successfully processed. Once a prescription reaches a pharmacy, changes are restricted; cancelling future renewals is a separate issue.

Check the official Coby Health program page for the current offer and conditions.

03. Mochi Health

A different way to pay for continuing care: membership plus medication. Compare the recurring total and the clinical access you would use, rather than the medication line alone.

Mochi advertises a $39 first membership month for eligible new subscribers and a $79 ongoing monthly membership. Its August 2026 pricing explanation describes dose-based compounded semaglutide prices of $60–$99 and tirzepatide prices of $90–$199, with medication billed separately.

Mochi’s pricing article says its transition to dose-based prices did not change the pharmacies or additives for the plans discussed. It does not identify your personal dispensing pharmacy. Confirm the pharmacy and complete formulation shown in your own care plan.

Continue with our Mochi Health review and pricing details.

04. Shapely

A candidate when your concern is access to scheduled provider visits or a dietitian. Its care membership excludes medicine, so a low introductory membership charge is not a drug price.

Shapely lists a $49 first self-pay membership month followed by $99 per month. Medication is excluded, and the site separately lists medication starting prices and possible lab charges. Its insured pathway requires an individual coverage check.

Confirm which visits your plan covers and which services belong to the selected membership. Acceptance of an insurance plan does not establish coverage of a weight-loss prescription.

Check the official Shapely program page for the current offer and conditions. Our Shapely alternatives comparison examines other care models.

05. Yucca Health

Offers a clear published contrast between monthly and six-month pricing. That makes it useful when you want to put the cash cost of flexibility beside Brello’s minimum term.

Yucca lists semaglutide at $125 per month on a six-month plan totaling $750, or $146 month to month. Tirzepatide is listed at $225 per month on a six-month plan totaling $1,350, or $258 month to month.

The $125 headline is a prepaid-plan equivalent, not the monthly-plan charge. Keep the selected term, renewal price, and cancellation policy with the purchase summary.

Check the official Yucca Health program page for the current offer and conditions. Our Yucca Health alternatives comparison examines other care models.

06. GobyMeds

A bundle-based alternative that also advertises no membership fee. Its starter package remains prepaid, so it does not solve a desire for month-to-month payments merely by removing a membership charge.

GobyMeds lists a three-month semaglutide starter bundle at $299 total and a tirzepatide starter bundle at $399 total. Its $99 and $133 monthly headlines describe those bundles; the page says the lowest figures can reflect multi-month or introductory offers.

Cancellation depends on whether the prescription has reached the pharmacy. A prepaid starter bundle is not a guarantee of the same renewal price, and HSA/FSA payment is not insurance coverage.

Check the official GobyMeds program page for the current offer and conditions.

The current Brello Health baseline

Brello displays semaglutide at $133 and tirzepatide at $166 per month as three-month-plan equivalents. Its terms on the same page require a three-month minimum and describe automatic renewal every 11 weeks at the rate shown at checkout.

Brello describes an online intake, provider review, a U.S. 503A partner pharmacy, an app, and virtual fitness and nutrition classes. Those classes are not necessarily individual dietitian appointments.

Read the renewal date as well as the minimum term. The FAQ describes a possible $50 professional-services deduction for qualifying cancellation requests made within 24 hours of the completed provider review; this is not an unconditional refund promise.

The details that decide this comparison

Write down the next renewal date rather than adding three calendar months to a receipt. An 11-week renewal can occur before a shopper expects it.

Separate group fitness or nutrition classes from individual clinical or dietitian appointments. They serve different needs and are not interchangeable.

Ask what happens if the clinician changes the treatment before the prepaid term ends. Stopping future renewal and refunding an existing order are separate questions.

Keep the treatment distinction clear

An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.

Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.

Before you make a change

Keep a record of any cancellation request and confirm whether it affects the next renewal, the current prescription, or both. Do not infer refund eligibility from a “cancel anytime” headline.

If the reason for moving is clinical support, arrange a conversation with the next prescriber before interrupting care. Neither an app nor a community can authorize a medication change.

Sources & research notes

Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

  1. CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
  2. CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
  3. CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
  4. CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
  5. CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
  6. Coby Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  7. Online Medical Weight Loss Program | Mochi HealthProvider-published information · Checked September 21, 2026
  8. Mochi: August 2026 dose-based pricingProvider-published information · Checked September 21, 2026
  9. Contact us | Mochi HealthProvider-published information · Checked September 21, 2026
  10. Shapely: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  11. Yucca Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  12. GobyMeds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  13. Brello Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  14. FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
  15. FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026

Read our methodology · Commercial disclosure · Request a correction